Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Pretargeted approach for tumor PET imaging using supramolecular nanoparticles with in vivo bioorthogonal chemistry

Yan Xing, Jin-sil Choi, Jinliang Peng, Wei-Yu Lin, Guoquan Li, Peter Conti, Hsian-Rong Tseng and Kai Chen
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 277;
Yan Xing
1Department of Radiology, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin-sil Choi
2Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinliang Peng
2Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei-Yu Lin
2Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guoquan Li
1Department of Radiology, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Conti
1Department of Radiology, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsian-Rong Tseng
2Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Chen
1Department of Radiology, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

277

Objectives The aim of this study is to employ a pretargeted approach that leverages the power of a supramolecular nanoparticle (SNP) vector and in vivo bioorthogonal chemistry for improved tumor PET imaging.

Methods A reactive bioorthogonal motif (a trans-cyclooctene group, TCO) was encapsulated into an SNP vector (TCO-SNPs) constructed from adamantane-grafted polyamidoamine dendrimers, adamantane-functionalized polyethylene glycol, and β-cyclodextrin-grafted branched polyethylenimine. A complementary bioorthogonal motif (a tetrazine group, Tz) was radiolabeled with 18F to afford a radiolabeled reporter (18F-Tz). Transmission electron microscope (TEM) was used for directly examining the morphology and size of SNPs. Static microPET scans were performed at various time points after iv injection of 18F-Tz in U87MG glioblastoma mouse xenografts.

Results The TEM measurements indicated that the size of SNPs was about 100 nm. The total synthesis time for 18F-Tz, including final high-performance liquid chromatography purification, was about 150 min. The decay-corrected radiochemical yield was 12±3% (n = 6). PET imaging results showed that the U87MG tumors can be clearly visualized as early as at 30 min postinjection of 18F-Tz, suggesting that the in vivo bioconjugation of TCO-grafted molecular building block and 18F-Tz was very rapid. Good tumor retention of radioactivity was observed from PET imaging. At 2 h pi, the tumor-to-muscle (T/M) ratio can reach 2.94±0.48. Ex vivo studies further confirmed the in vivo imaging findings.

Conclusions We have demonstrated a new pretargeted approach to achieve improved tumor PET imaging. The new strategy decouples a tumor-targeting agent (such as nanoparticles) from a radiolabeled imaging agent, leading to a superb capability of optimizing the PKs of both nanoparticles and radiolabeled imaging agents to obtain optimal in vivo imaging performances.

Research Support This work was supported by the USC Department of Radiology.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pretargeted approach for tumor PET imaging using supramolecular nanoparticles with in vivo bioorthogonal chemistry
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pretargeted approach for tumor PET imaging using supramolecular nanoparticles with in vivo bioorthogonal chemistry
Yan Xing, Jin-sil Choi, Jinliang Peng, Wei-Yu Lin, Guoquan Li, Peter Conti, Hsian-Rong Tseng, Kai Chen
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 277;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pretargeted approach for tumor PET imaging using supramolecular nanoparticles with in vivo bioorthogonal chemistry
Yan Xing, Jin-sil Choi, Jinliang Peng, Wei-Yu Lin, Guoquan Li, Peter Conti, Hsian-Rong Tseng, Kai Chen
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 277;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • In vitro response of 177Lu-PSMA-617 with two different specific activities
  • Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
  • Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Antibody, Nanoparticle and Cell-Based Oncology Probes

  • Preclinical evaluation of anti-αvβ6 diabodies and anti-αvβ6 cys-diabodies for imaging αvβ6-positive tumors with positron emission tomography
  • PET of follicle-stimulating hormone receptor: Broadly applicable for imaging of cancer
  • 111In-anti-F4/80 for in vivo tracking of tumor associated macrophages
Show more Antibody, Nanoparticle and Cell-Based Oncology Probes

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire